Declaration of Interest
CTU Bern, including CTU Bern staff, aims at being independent of financially driven biases. CTU Bern acknowledges that clinical research is costly and some research would not be possible without financial support from organizations that have a vested interest (non-financial interests are not covered herein) in the results of the research they support. Therefore, CTU Bern aims at transparency and minimizing financial biases.
CTU Bern has a funding policy that is binding to all staff.
Funding of clinical studies
CTU Bern may be involved in studies that are funded by for-profit organizations with a commercial interest in healthcare. However, CTU Bern ensures transparent reporting of funding sources and endorses access to all study data by academic researchers and unbiased and unrestricted publication of study results. CTU Bern is and will not be involved in any clinical study (co-)funded by the tobacco industry.
List of funding sources
Only major projects listed
|0533||OPTICO BVS||St. Jude Medical|
|0453||TOLERANT||Bayer (Schweiz) AG|
Mundipharma Medical Company
|0536||SAAL||Miltenyi Biotec GmbH|
Novartis Pharma Schweiz AG
|0468||OSCAR GALILEO||Bayer AG|
|0628||SCOPE I||Symetis SA|
|0670||DAWN2 CH||Novo Nordisk AG|
||Terumo Medical Corporation|
|0632||SYMPTOM NAVI Pilot||Stiftung Lindenhof Bern|
|0613||SCRIPT||University of Bern|
REVEAL in TAVI
Medtronic (Schweiz) AG